Option Care Health (NASDAQ:OPCH) Issues FY 2025 Earnings Guidance

Option Care Health (NASDAQ:OPCH) issued an update on its FY 2025 earnings guidance on Tuesday morning. The company provided EPS guidance of 1.590-1.690 for the period, compared to the consensus EPS estimate of 1.330. The company issued revenue guidance of $5.3 billion-$5.5 billion, compared to the consensus revenue estimate of $5.3 billion.

Option Care Health Trading Up 1.4 %

NASDAQ OPCH opened at $34.60 on Thursday. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. The firm has a market cap of $5.72 billion, a P/E ratio of 29.08, a P/E/G ratio of 2.30 and a beta of 1.33. Option Care Health has a one year low of $21.39 and a one year high of $34.85. The stock’s 50-day moving average is $29.38 and its 200-day moving average is $28.14.

Analyst Ratings Changes

OPCH has been the subject of a number of research reports. UBS Group initiated coverage on Option Care Health in a report on Thursday, December 5th. They set a “neutral” rating and a $26.00 price objective for the company. Barrington Research increased their price objective on Option Care Health from $33.00 to $38.00 and gave the stock an “outperform” rating in a report on Thursday, February 27th. JPMorgan Chase & Co. increased their price objective on Option Care Health from $38.00 to $40.00 and gave the stock an “overweight” rating in a report on Friday, January 24th. Bank of America upgraded Option Care Health from a “neutral” rating to a “buy” rating and raised their price target for the company from $26.00 to $33.00 in a research note on Monday, January 13th. Finally, Jefferies Financial Group upgraded Option Care Health from a “hold” rating to a “buy” rating and raised their price target for the company from $26.00 to $35.00 in a research note on Thursday, January 23rd. Two investment analysts have rated the stock with a hold rating and six have given a buy rating to the company’s stock. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $32.88.

Insider Buying and Selling at Option Care Health

In other news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the transaction, the insider now owns 44,974 shares in the company, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 0.64% of the company’s stock.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.